Menu
Nanotein & Akron Bio Partner for cGMP production of NanoSpark® STEM-T Soluble T Cell Activator. Read More
Advanced protein-based soluble activation enhances the quality and quantity of your next immunotherapy.
Our technology is able to produce larger quantities of CAR-T cells in less time than competitor reagents.
We use protein-based components in our manufacturing, eliminating the risk of synthetic contaminants.
Clinical research showed high rates of tumor destruction and remission in patients by the types of T cell profile Nanotein’s product expands.
CAR-T cells are the most clinically and commercially advanced of the anti-cancer cell therapies. While incredibly effective, they have faced multiple challenges, especially attributed to manufacturing. We at Nanotein work to address these challenges by greatly improving the quality and quantity of T cells produced.
Cancer cell therapies are the cancer treatment of the future. The foundation of CAR-T cell therapies is the T cells from which they are generated. The degree of stemness and overall quality of these cells are critical to CAR-T’s therapeutic success.
We anticipate hiring in the near future. Check back in for current career opportunities.
Subscribe to Our Newsletter
